Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.
Klonowska K, Thiele EA, Grevelink JM, Thorner AR, Kwiatkowski DJ.
J Med Genet. 2022 Sep;59(9):920-923. doi: 10.1136/jmedgenet-2021-108160. Epub 2021 Oct 11.
Tuberous Sclerosis Complex: A Review.
Randle SC.
Pediatr Ann. 2017 Apr 1;46(4):e166-e171. doi: 10.3928/19382359-20170320-01.
Tuberous Sclerosis Complex.
Islam MP.
Semin Pediatr Neurol. 2021 Apr;37:100875. doi: 10.1016/j.spen.2021.100875. Epub 2021 Feb 11.
Tuberous sclerosis complex: review based on new diagnostic criteria.
Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM.
An Bras Dermatol. 2018 Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972.
Tuberous sclerosis.
Curatolo P, Bombardieri R, Jozwiak S.
Lancet. 2008 Aug 23;372(9639):657-68. doi: 10.1016/S0140-6736(08)61279-9.
Facial Angiofibroma Severity Index: A beneficial tool to evaluate the treatment response in the skin of colour.
Hongal AA, Aithal SS, Revathi TN.
Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):130-132. doi: 10.25259/IJDVL_1161_2021.
Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
Boggarapu S, Roberds SL, Nakagawa J, Beresford E.
Orphanet J Rare Dis. 2022 Sep 14;17(1):355. doi: 10.1186/s13023-022-02496-2.
Unilateral Facial Angiofibromas.
Basu D, Kumar P, Das A.
Skinmed. 2019 Mar 19;17(1):52-53. eCollection 2019.
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ, Heunis TM, Vanclooster S, Chambers N, Bissell S, Byars AW, Flinn J, Gipson TT, van Eeghen AM, Waltereit R, Capal JK, Cukier S, Davis PE, Smith C, Kingswood JC, Schoeters E, Srivastava S, Takei M, Gardner-Lubbe S, Kumm AJ, Krueger DA, Sahin M, De Waele L, Jansen AC.
J Neurodev Disord. 2023 Sep 14;15(1):32. doi: 10.1186/s11689-023-09500-1.
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ.
Am J Hum Genet. 2001 Jan;68(1):64-80. doi: 10.1086/316951. Epub 2000 Dec 8.
